CD4 and myeloid sarcoma: De Santis et al. [17] performed a genome-wide expression analysis of miRNAs in regulatory T (Treg) CD4+ cells that lose their capacity to suppress the activation of the immune system and maintain homeostasis and tolerance to self-antigens in the course of MS [17].